Hipertens Riesgo Vasc. 2024 Dec 6:S1889-1837(24)00111-9. doi: 10.1016/j.hipert.2024.10.003. Online ahead of print.
ABSTRACT
INTRODUCTION: This study investigates the perceptions and knowledge of specialized Argentine physicians regarding renal denervation (RDN) as a treatment for resistant hypertension (R-HT).
METHOD: A survey was conducted among 206 physicians, mainly cardiologists and internists, to assess their awareness and perceptions of RDN. Data were analyzed using descriptive statistics and Spearman’s Rho correlation.
RESULTS: The survey revealed that 83% of the responders are aware of RDN. Despite this high awareness, only 60% believe in its safety, while 33.2% are uncertain, and 6.8% consider it unsafe. Significant correlations were found between the awareness of RDN and perceptions of its efficacy and safety.
CONCLUSIONS: The study highlights a gap between knowledge and confidence in RDN among specialized Argentine physicians. Continuous education and shared decision-making are crucial to improve the adoption of RDN in clinical practice. Long-term safety and efficacy data support RDN as a valuable tool for managing R-HT. Addressing safety concerns through targeted educational initiatives is essential.
PMID:39645419 | DOI:10.1016/j.hipert.2024.10.003
